G LP-1 receptor agonists (GLP1RAs) increased the intestinal Bacteroidetes to Firmicutes ratio, decreased obesity-related but increased lean-related microbiota phenotypes, and implement bacteria with anti-inflammatory properties (i.e., Akkermansia) [110]. Here, GLP1R is linked to Obesity.